Share
Market Research Report

LUNG CANCER DIAGNOSTIC AND SCREENING MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Segmentation
  • By Test TypeBiomarkers Test (EGFR Mutation Test, KRAS Mutation Test, ALK Test, HER2 Test, Others) Imaging Test (Computed Tomography (CT) scan, Positron Emission Tomography (PET) scan, Chest X-Ray, Others) · Biopsy
  • By Cancer TypeNon-small cell lung cancer · Small Cell Lung Cancer Neurosurgery
  • By End UserHospital Associated Labs · Independent Diagnostic Laboratories · Cancer Research Institutes · Others
  • By GeographyNorth America · Latin America · Europe · Asia Pacific · Middle East & Africa
  • Published In01 Jul 2026
  • Report CodeCMI4434
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026-2033

Market Segmentation

  • By Test Type

    • Biomarkers Test
      • EGFR Mutation Test
      • KRAS Mutation Test
      • ALK Test
      • HER2 Test
      • Others
    • Imaging Test
      • Computed Tomography (CT) scan
      • Positron Emission Tomography (PET) scan
      • Chest X-Ray
      • Others
    • Biopsy 

  • By Cancer Type

    • Non-small cell lung cancer
    • Small Cell Lung Cancer Neurosurgery

  • By End User 

    • Hospital Associated Labs
    • Independent Diagnostic Laboratories
    • Cancer Research Institutes
    • Others

  • By Region

    • North America
      • U.S.
      • Canada
    • Latin America
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • South Africa
      • Central Africa
      • North Africa